APLT insider transactions
Applied Therapeutics Inc. (APLT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for APLT
- Director Kanter Stacy J. returned 22,500 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Commercial Officer Hooks Corwin Dale was granted 312,500 shares and returned 862,500 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Officer Chinoporos Constantine was granted 437,500 shares and returned 1,000,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Director Skyler Jay S returned 22,500 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Financial Officer Funtleyder Leslie D. was granted 1,187,500 shares and returned 2,375,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Medical Officer Bailey Evan Prescott returned 1,235,915 shares to the company and was granted 437,500 shares, closing all direct ownership in the company (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Director Lerner Teena returned 22,500 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Financial Officer Funtleyder Leslie D. was granted 150,000 shares, increasing direct ownership by 13% to 1,340,459 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Director Kanter Stacy J. sold $4,816 worth of shares (43,000 units at $0.11), decreasing direct ownership by 40% to 65,000 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Financial Officer Funtleyder Leslie D. was granted 150,000 shares, increasing direct ownership by 14% to 1,190,459 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Financial Officer Funtleyder Leslie D. was granted 300,000 shares, increasing direct ownership by 47% to 937,121 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Medical Officer Bailey Evan Prescott was granted 300,000 shares, increasing direct ownership by 55% to 841,669 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- New insider Bailey Evan Prescott claimed ownership of 541,669 shares (SEC Form 3)3 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- SEC Form 4 filed by Director Lerner Teena4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- SEC Form 4 filed by Director Skyler Jay S4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- SEC Form 4 filed by Director Kanter Stacy J.4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Commercial Officer Hooks Corwin Dale was granted 250,000 shares, increasing direct ownership by 83% to 550,000 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Officer Funtleyder Leslie D. was granted 350,000 shares, increasing direct ownership by 90% to 740,459 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Officer Chinoporos Constantine was granted 350,000 shares, increasing direct ownership by 129% to 621,436 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Medical Officer Perfetti Riccardo sold $4,561 worth of shares (10,366 units at $0.44), decreasing direct ownership by 1% to 890,409 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Officer Funtleyder Leslie D. sold $6,381 worth of shares (14,502 units at $0.44), decreasing direct ownership by 4% to 390,459 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Officer Chinoporos Constantine sold $197 worth of shares (447 units at $0.44), decreasing direct ownership by 0.16% to 271,436 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Officer Funtleyder Leslie D. sold $14,000 worth of shares (22,950 units at $0.61), decreasing direct ownership by 5% to 404,961 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Medical Officer Perfetti Riccardo sold $52,508 worth of shares (86,078 units at $0.61), decreasing direct ownership by 9% to 900,775 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Officer Chinoporos Constantine sold $17,151 worth of shares (28,117 units at $0.61), decreasing direct ownership by 9% to 271,883 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Executive Chairman Johnson John was granted 500,000 shares (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Officer Funtleyder Leslie D. was granted 150,000 shares, increasing direct ownership by 54% to 427,911 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- SEC Form 3 filed by new insider Johnson John3 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Financial Officer Funtleyder Leslie D. sold $78,880 worth of shares (13,530 units at $5.83), decreasing direct ownership by 5% to 277,911 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Medical Officer Perfetti Riccardo sold $132,230 worth of shares (22,681 units at $5.83), decreasing direct ownership by 2% to 986,853 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- President and CEO Shendelman Shoshana gifted 747,886 shares, received a gift of 747,886 shares and sold $4,712,049 worth of shares (777,014 units at $6.06), decreasing direct ownership by 14% to 4,690,839 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- President and CEO Shendelman Shoshana sold $266,954 worth of shares (61,795 units at $4.32), decreasing direct ownership by 2% to 3,756,019 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Medical Officer Perfetti Riccardo sold $95,053 worth of shares (22,003 units at $4.32), decreasing direct ownership by 2% to 1,009,534 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chief Financial Officer Funtleyder Leslie D. sold $73,354 worth of shares (16,980 units at $4.32), decreasing direct ownership by 6% to 291,441 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Kanter Stacy J. was granted 45,000 shares, increasing direct ownership by 71% to 108,000 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Skyler Jay S was granted 45,000 shares, increasing direct ownership by 225% to 65,000 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Marcus Joel S was granted 45,000 shares, increasing direct ownership by 10% to 498,414 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Lerner Teena was granted 45,000 shares, increasing direct ownership by 74% to 105,422 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Alexandria Real Estate Equities, Inc. sold $1,267,500 worth of shares (300,000 units at $4.22) (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Hooks Corwin Dale was granted 300,000 shares (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- SEC Form 3 filed by new insider Hooks Corwin Dale3 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Shendelman Shoshana sold $1,717,108 worth of shares (318,573 units at $5.39), decreasing direct ownership by 8% to 3,817,814 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Perfetti Riccardo sold $597,234 worth of shares (110,804 units at $5.39), decreasing direct ownership by 10% to 1,031,537 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Hansard Adam sold $263,415 worth of shares (48,871 units at $5.39), decreasing direct ownership by 6% to 732,919 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Funtleyder Leslie D. sold $154,839 worth of shares (28,727 units at $5.39), decreasing direct ownership by 9% to 308,421 units (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Chinoporos Constantine was granted 300,000 shares (SEC Form 4)4 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- SEC Form 3 filed by new insider Chinoporos Constantine3 - Applied Therapeutics, Inc. (0001697532) (Issuer)
- Shendelman Shoshana was granted 1,540,000 shares, increasing direct ownership by 59% to 4,136,387 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Perfetti Riccardo was granted 450,000 shares, increasing direct ownership by 65% to 1,142,341 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Hansard Adam was granted 400,000 shares, increasing direct ownership by 105% to 781,790 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Kanter Stacy J. bought $65,367 worth of shares (30,000 units at $2.18), increasing direct ownership by 91% to 63,000 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Shendelman Shoshana sold $7,817 worth of shares (3,968 units at $1.97), decreasing direct ownership by 0.15% to 2,596,387 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Perfetti Riccardo sold $3,119 worth of shares (1,583 units at $1.97), decreasing direct ownership by 0.23% to 692,341 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Hansard Adam sold $1,901 worth of shares (965 units at $1.97), decreasing direct ownership by 0.25% to 381,790 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Alexandria Real Estate Equities, Inc. acquired 575,000 shares and disposed of 575,000 shares (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Funtleyder Leslie D. was granted 300,000 shares, increasing direct ownership by 808% to 337,148 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Alexandria Real Estate Equities, Inc. sold $572,204 worth of shares (247,258 units at $2.31) (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Alexandria Real Estate Equities, Inc. sold $781,221 worth of shares (327,742 units at $2.38) (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Alexandria Real Estate Equities, Inc. disposed of 1,600,000 shares and acquired 1,600,000 shares (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)
- Shendelman Shoshana sold $312,206 worth of shares (115,632 units at $2.70), decreasing direct ownership by 4% to 2,600,355 units (SEC Form 4)4 - Applied Therapeutics Inc. (0001697532) (Issuer)